Janssen Pharmaceutica NV

At Janssen Research & Development, we are united and energized by one mission - to discover and develop innovative medicines that ease patient’s suffering, and solve the most important unmet medical needs of our time.

As one of the Janssen Pharmaceutical Companies, our strategy is to identify the biggest unmet medical needs and match them with the best science, internal or external, to find solutions for patients worldwide. We leverage our world-class discovery and development expertise, and operational excellence, to bring innovative, effective treatments in five therapeutic areas:

  • cardiovascular and metabolism
  • immunology
  • infectious diseases and vaccines
  • neuroscience
  • oncology

We think of the world as our laboratory and we look for innovation wherever it exists. This drives our relentless search for the best science, and our pursuit of collaborations and partnerships. We believe there are no limits to what science can do. And we never lose sight of those who rely most on our discoveries. 

Key staff involved in EBiSC

Andreas Ebneth (Senior Principal Scientist) – Neuroscience Therapeutic Area
Andreas holds a PhD in Biochemistry and joined Janssen in 2012. Before he was working on neurodegenerative diseases with focus on Huntington’s and Alzheimer’s disease. 

In 2017, Andreas took over the role of the EBiSC Project Coordinator from Tim Allsopp (Pfizer).

Alfredo Cabrera-Socorro (PostDoctoral Scientist) – Neuroscience Therapeutic Area
Alfredo has recently joined Janssen and holds a  PhD in Cell and Molecular Biology. With a background in neuroscience and stem cell biology, his research has been focused in pathologies affecting brain development and function.

More information: www.janssenrnd.com »